Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine

被引：7
作者：
Milazzo, L [1 ]
Rusconi, S
Testa, L
La Seta-Catamancio, S
Galazzi, M
Kurtagic, S
Citterio, P
Gianotto, M
Grassini, A
Adorni, F
d'Arminio-Monforte, A
Galli, M
Moroni, M
机构：
[1] Univ Milan, Osped Luigi Sacco, Ist Malattie Infett & Trop, Milan, Italy
[2] CNR, Ist Tecnol Biomed Avanzate, I-20131 Milan, Italy
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1999年 / 22卷 / 01期
关键词：
D O I：
10.1097/00042560-199909010-00013
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：101 / 103
页数：3
相关论文
共 15 条
[11]   2-DRUG COMBINATIONS OF ZIDOVUDINE, DIDANOSINE, AND RECOMBINANT INTERFERON-ALPHA A INHIBIT REPLICATION OF ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNERGISTICALLY INVITRO [J].
JOHNSON, VA ;
MERRILL, DP ;
VIDELER, JA ;
CHOU, TC ;
BYINGTON, RE ;
ERON, JJ ;
DAQUILA, RT ;
HIRSCH, MS .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) :646-655
[12]   POTENTIAL MECHANISM FOR SUSTAINED ANTIRETROVIRAL EFFICACY OF AZT-3TC COMBINATION THERAPY [J].
LARDER, BA ;
KEMP, SD ;
HARRIGAN, PR .
SCIENCE, 1995, 269 (5224) :696-699
[13]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860
[14]  
RUSCONI S, 1997, ANTIVIR THER, V2, P41
[15]   Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment [J].
Winters, MA ;
Schapiro, JM ;
Lawrence, J ;
Merigan, TC .
JOURNAL OF VIROLOGY, 1998, 72 (06) :5303-5306
12